보고서 요약(국문)

시장 개요
전 세계 혈관 이식재 시장은 2022년 24억 8,330만 달러에 달했으며, 2030년까지 44억 400만 달러에 이르는 높은 성장세를 보일 것으로 예상됩니다. 혈관 이식재 시장은 예측 기간(2023~2030년) 동안 연평균 7.6%의 성장률을 기록할 것으로 전망됩니다.
혈관 이식재는 혈관 우회술 시 혈관을 연결하여 혈류를 한 곳에서 다른 곳으로 전환하는 의료 기기입니다. 혈관 이식재는 동맥 협착을 우회하고, 손상된 부위에 혈류를 회복시키며, 다양한 수술 중 심장마비나 뇌졸중과 같은 합병증을 예방하는 데 도움을 줍니다.
심혈관 질환의 증가, 혈관 수술 기술의 발전, 그리고 고령화는 모두 예측 기간 동안 전 세계 혈관 이식재 시장 성장에 기여할 것으로 예상됩니다.

시장 동향
투석 시술 건수 증가와 만성 신장 질환(CKD) 환자 수 증가가 전 세계 혈관 이식 시장 성장을 견인할 것으로 예상됩니다.
전 세계적으로 투석 시술 건수가 증가하고 만성 신장 질환(CKD) 환자가 늘어나면서 전 세계 혈관 이식 시장의 성장이 촉진되고 있습니다. CKD는 전 세계적으로 8억 명 이상이 앓고 있는 퇴행성 질환입니다. 예를 들어, 2022년 Kidney International Supplements 저널에 발표된 연구에 따르면 CKD 유병률 증가는 투석 시술에 필요한 혈관 이식 수요를 증가시킬 것입니다.
또한, 미국 신장 재단(American Kidney Fund) 보고서에 따르면 신장 질환은 약 3,700만 명의 미국인에게 영향을 미치며, 미국 내 10대 사망 원인 중 하나인 신부전은 약 81만 명에게 영향을 미칩니다. 따라서 이러한 요인들로 인해 전 세계 혈관 이식 시장은 예측 기간 동안 성장을 보일 것으로 예상됩니다.

전 세계 혈관 이식 시장은 높은 비용으로 인해 제약을 받을 수 있습니다.
혈관 이식재의 높은 비용은 전 세계 혈관 이식재 시장 성장의 주요 제약 요인입니다. 혈관 이식재 가격은 사용되는 재료의 종류와 수술의 복잡성에 따라 다릅니다. 예를 들어, 합성 이식재는 생체 이식재보다 가격이 저렴한 경향이 있지만 항상 성공률이 높은 것은 아닙니다. 높은 가격 때문에 개발도상국 환자나 의료 보험이 없는 환자에게는 이러한 제품이 부담스러울 수 있습니다.
코로나19 영향 분석
코로나19 발생으로 인해 사업 운영, 공급망, 유통 시스템 등이 차질을 빚으면서 혈관 이식재 시장에 부정적인 영향을 미쳤습니다. 코로나바이러스 확산을 막기 위해 다른 선택적 수술들이 취소되거나 연기되었습니다. 또한 의료진이 코로나19 치료에 집중하면서 필수적이지 않은 수술 건수가 줄었습니다.

러시아-우크라이나 분쟁 분석
러시아와 우크라이나 간의 분쟁은 세계 혈관 이식재 시장에 직접적인 영향을 미치지 않았습니다. 분쟁으로 인해 지정학적 불안정과 경제 제재가 발생했지만, 혈관 이식재의 생산 및 유통은 러시아나 우크라이나 어느 한쪽에 크게 의존하지 않습니다. 혈관 이식재 시장의 주요 참여 기업들은 대부분 전 세계에 사업장과 공급망을 보유한 다국적 기업입니다.
혈관 이식재는 주로 의료 치료에 사용되며, 지정학적 요인보다는 환자의 요구와 의료 규정에 따라 수요가 결정됩니다. 러시아-우크라이나 전쟁은 혈관 이식재 공급에 일시적이고 소규모의 영향만 미칠 것으로 예상되지만, 해당 지역의 분쟁이 장기화되거나 불안정이 지속될 경우 혈관 이식재 시장을 포함한 전 세계 의료 산업에 더 광범위한 영향을 미칠 수 있습니다.
세분화 분석
세계 혈관 이식재 시장은 제품, 원자재, 최종 사용자 및 지역별로 세분화됩니다.

병원 부문이 전 세계 혈관 이식 시장을 주도할 것으로 예상됩니다.
병원 부문은 전 세계 혈관 이식 시장에서 38.3%의 가장 높은 시장 점유율을 차지하며 시장을 주도하고 있습니다. 혈관 이식은 심혈관 질환 및 만성 신장 질환을 포함한 만성 질환의 증가로 인해 병원에서 더욱 흔해진 여러 수술 절차 중 하나입니다. 결과적으로 병원은 혈관 이식 최종 사용자의 대부분을 차지합니다.
병원 최종 사용자 부문의 확장은 병원 치료에 대한 공공 및 민간 보험 프로그램의 보급으로 더욱 가속화되고 있습니다. 환자들은 보험을 통해 혈관 이식 수술을 받을 수 있어 접근성과 경제성이 향상됩니다. 따라서 이러한 요인들로 인해 병원 부문은 전 세계 혈관 이식 시장 성장을 가속화하는 데 중요한 역할을 할 것으로 예상됩니다.
지역 분석
북미 지역이 전 세계 혈관 이식 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.

전 세계 혈관 이식재 시장은 북미가 주도하며, 당뇨병, 심혈관 질환, 만성 신장 질환의 높은 유병률로 인해 시장 점유율 3분의 1을 차지하고 있습니다. 북미 시장의 성장은 의료 보험 적용 범위 확대와 최첨단 의료 인프라 접근성에 힘입어 가속화되고 있습니다. 생체 재료 혈관 이식재 시장의 성장은 조직 공학을 통해 개발된 특정 제품의 등장과 함께 지속적인 기술 발전에 의해 촉진되고 있습니다.
또한, 개선된 의료 보험 정책, 최첨단 기술, 효과적인 정책, 생체 측정 기기를 활용한 정밀 진단 과정 등이 시장 성장의 주요 요인입니다. 더 나아가, 첨단 생체 재료 이식재 개발에 대한 지속적인 연구는 해당 지역의 제품 수요를 증가시킬 것으로 예상됩니다.

경쟁 환경
시장의 주요 글로벌 업체로는 Abbott Laboratories, Braun Melsungen AG, Bard Peripheral Vascular Inc., Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, 그리고 W.L. Gore & Associates Inc. 등이 있습니다.
보고서 구매 이유

• 제품, 원자재, 최종 사용자 및 지역별 글로벌 혈관 이식재 시장 세분화를 시각화하고 주요 사업 자산 및 업체를 파악하기 위해

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴하기 위해

• 모든 세그먼트를 포함한 글로벌 혈관 이식재 시장의 다양한 데이터 포인트가 담긴 Excel 데이터 시트 제공

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서 제공

• 주요 업체들의 핵심 제품 목록이 담긴 Excel 파일 제공 글로벌 혈관 이식재 시장 보고서는 약 53개의 표, 54개의 그림, 그리고 195페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The global vascular graft market reached US$ 2,483.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 4,404.0 million by 2030. The vascular graft market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030).
Vascular grafts are medical devices that connect blood vessels during vascular bypass treatments to redirect blood flow from one location to another. They help to circumvent constrictions in blood arteries, restore blood flow to injured areas, and avoid problems like heart attacks and strokes during a variety of surgical operations.
The rising frequency of cardiovascular illnesses, technical improvements in vascular surgery, and the aging population are all expected to contribute to the global vascular graft market growth over the forecast period.
Market Dynamics
The Rising Number of Dialysis Procedures and a Rise in Cases of Chronic Kidney Disease (CKD) Are Expected to Drive the Global Vascular Graft Market Growth.
The growing number of dialysis procedures and a rise in cases of chronic kidney disease (CKD) worldwide are driving the growth of the global vascular graft market. CKD is a degenerative disease that now affects more than 800 million people worldwide. For instance, according to research that was published in the Journal Kidney International Supplements in 2022, the rising prevalence of CKD will increase the demand for vascular grafts in dialysis procedures.
Furthermore, according to the report by the American Kidney Fund, renal disease affects approximately 37 million Americans, and kidney failure, one of the top 10 leading causes of mortality in the country, affects around 810,000 people. Therefore, owing to the above factors, the global vascular graft market will witness growth over the forecast period.
The Global Vascular Graft Market May Face Constraints Due to High Cost of Vascular Grafts.
The high cost associated with the vascular graft is the major restraint for global vascular graft market growth. The vascular graft prices vary based on the kind of material used and how complicated the surgery is, for instance, synthetic grafts tend to be less expensive than biological ones, but they might not always be as successful. The products could not be affordable for patients in underdeveloped nations or for those without insurance because of their high price.
COVID-19 Impact Analysis
Due to the disruption in business operations, supply chains, distribution systems, etc., the COVID-19 outbreak had a negative effect on the market for vascular grafts. In order to stop the coronavirus from spreading, other elective procedures were either cancelled or put off. Additionally, because healthcare providers were concentrating on COVID-19 treatment, fewer non-essential surgeries were performed.
Russia Ukraine Conflict Analysis
The world market for vascular grafts has not been specifically impacted by the conflict between Russia and Ukraine. Although the conflict has caused geopolitical unrest and economic sanctions, the production and distribution of vascular grafts are not heavily reliant on either Russia or Ukraine. The majority of the top market participants for vascular grafts are multinational corporations with operations and supply networks dispersed around the globe.
Vascular grafts are mostly employed in medical treatments, and rather than being influenced by geopolitics, the demand for these devices is largely driven by patient demands and healthcare regulations. The Russia-Ukraine war is only anticipated to have a transient and small-scale impact on the availability of vascular grafts, , but any prolonged conflict or instability in the region could have wider implications for the global healthcare industry, including the vascular grafts market.
Segment Analysis
The global vascular graft market is segmented based on product, raw material, end user, and region.
The Hospitals Segment is Expected to Dominate the Global Vascular Graft Market.
The hospitals sgement dominated the global vascular graft market and accounted the highest vascular graft market share of 38.3%. Vascular grafting is one of the many surgical procedures that have become more common in hospitals as a result of the rising burden of chronic illnesses including cardiovascular disease and chronic renal disease. As a result, hospitals make up the majority of vascular transplant end users.
The expansion of the hospital end user sector is also being fueled by the availability of public and private insurance programmes for hospital treatments. Vascular graft surgeries can be obtained by patients through insurance plans, which increases their accessibility and affordability. Therefore, owing to the above factors, the hospiatals segment is likely to play major role in accelarating the global vascular graft market growth.
Geographical Analysis
North America Region Holds The Largest Market Share of the Global Vascular Graft Market.
The global vascular graft market is dominated by North America and holds 1/3rd market share, due to the high prevalence of diabetes, cardiovascular disease, and chronic kidney disease. The expansion of this market in North America is being fueled by the presence of reimbursement coverage and the accessibility of cutting-edge healthcare infrastructure. The expansion of biomaterials vascular grafts is sparked by ongoing technical advancements that are followed by the identification of particular goods made via tissue engineering.
Furthermore, the better reimbursement policies, cutting-edge technology, effective initiatives, and precise diagnostic processes using biometric instruments are some of the major contributors to the market's growth. Moreover, it is anticipated that ongoing research into the creation of advanced biomaterial grafts will increase demand for these products in the area.
Competitive Landscape
The major global players in the market include Abbott Laboratories, Braun Melsungen AG, Bard Peripheral Vascular Inc., Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, and W.L. Gore & Associates Inc.
Why Purchase the Report?
• To visualize the global vascular graft market segmentation based on product, raw material, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global vascular graft market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global vascular graft market report would provide approximately 53 tables, 54 figures and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Raw Material
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The rising number of dialysis procedures and a rise in cases of chronic kidney disease (CKD)
4.1.2. Restraints
4.1.2.1. High cost of vascular grafts.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Before COVID-19 Scenario
6.1.2. Present COVID-19 Scenario
6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Hemodialysis Access Graft
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Endovascular Aneurysm Repair Stent Graft
7.4. Peripheral Vascular Graft
8. By Raw Material
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
8.1.2. Market Attractiveness Index, By Raw Material
8.2. Polyester
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polytetrafluoroethylene (PTFE)
8.4. Polyurethane
8.5. Biosynthetic
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgery Center
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Abbott Laboratories*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Braun Melsungen AG
12.3. Bard Peripheral Vascular Inc. (BD)
12.4. Cardinal Health (Cordis Corporation)
12.5. Cook Medical
12.6. Cryolife
12.7. Getinge Group
12.8. LeMaitre Vascular Inc
12.9. Medtronic PLC
12.10. W.L. Gore & Associates Inc
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Abbott Laboratories, 4.	Key Developments, Braun Melsungen AG, Bard Peripheral Vascular Inc. (BD), Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, W.L. Gore & Associates Inc

표 목록 (Tables)

List of Tables

Table 1 Global Vascular Graft Market Value, By Product, 2023, 2027 & 2031 (USD Million)

Table 2 Global Vascular Graft Market Value, By Raw Material, 2023, 2027 & 2031 (USD Million)

Table 3 Global Vascular Graft Market Value, By End User, 2023, 2027 & 2031 (USD Million)

Table 4 Global Vascular Graft Market Value, By Region, 2023, 2027 & 2031 (USD Million)

Table 5 Global Vascular Graft Market Value, By Product, 2023, 2027 & 2031 (USD Million)

Table 6 Global Vascular Graft Market Value, By Product, 2022-2031 (USD Million)

Table 7 Global Vascular Graft Market Value, By Raw Material, 2023, 2027 & 2031 (USD Million)

Table 8 Global Vascular Graft Market Value, By Raw Material, 2022-2031 (USD Million)

Table 9 Global Vascular Graft Market Value, By End User, 2023, 2027 & 2031 (USD Million)

Table 10 Global Vascular Graft Market Value, By End User, 2022-2031 (USD Million)

Table 11 Global Vascular Graft Market Value, By Region, 2023, 2027 & 2031 (USD Million)

Table 12 Global Vascular Graft Market Value, By Region, 2022-2031 (USD Million)

Table 13 North America Vascular Graft Market Value, By Product, 2022-2031 (USD Million)

Table 14 North America Vascular Graft Market Value, By Raw Material, 2022-2031 (USD Million)

Table 15 North America Vascular Graft Market Value, By End User, 2022-2031 (USD Million)

Table 16 North America Vascular Graft Market Value, By Country, 2022-2031 (USD Million)

Table 17 South America Vascular Graft Market Value, By Product, 2022-2031 (USD Million)

Table 18 South America Vascular Graft Market Value, By Raw Material, 2022-2031 (USD Million)

Table 19 South America Vascular Graft Market Value, By End User, 2022-2031 (USD Million)

Table 20 South America Vascular Graft Market Value, By Country, 2022-2031 (USD Million)

Table 21 Europe Vascular Graft Market Value, By Product, 2022-2031 (USD Million)

Table 22 Europe Vascular Graft Market Value, By Raw Material, 2022-2031 (USD Million)

Table 23 Europe Vascular Graft Market Value, By End User, 2022-2031 (USD Million)

Table 24 Europe Vascular Graft Market Value, By Country, 2022-2031 (USD Million)

Table 25 Asia-Pacific Vascular Graft Market Value, By Product, 2022-2031 (USD Million)

Table 26 Asia-Pacific Vascular Graft Market Value, By Raw Material, 2022-2031 (USD Million)

Table 27 Asia-Pacific Vascular Graft Market Value, By End User, 2022-2031 (USD Million)

Table 28 Asia-Pacific Vascular Graft Market Value, By Country, 2022-2031 (USD Million)

Table 29 Middle East & Africa Vascular Graft Market Value, By Product, 2022-2031 (USD Million)

Table 30 Middle East & Africa Vascular Graft Market Value, By Raw Material, 2022-2031 (USD Million)

Table 31 Middle East & Africa Vascular Graft Market Value, By End User, 2022-2031 (USD Million)

Table 32 Abbott Laboratories: Overview

Table 33 Abbott Laboratories: Product Portfolio

Table 34 Abbott Laboratories: Key Developments

Table 35 Braun Melsungen AG: Overview

Table 36 Braun Melsungen AG: Product Portfolio

Table 37 Braun Melsungen AG: Key Developments

Table 38 Bard Peripheral Vascular Inc. (BD): Overview

Table 39 Bard Peripheral Vascular Inc. (BD): Product Portfolio

Table 40 Bard Peripheral Vascular Inc. (BD): Key Developments

Table 41 Cardinal Health (Cordis Corporation): Overview

Table 42 Cardinal Health (Cordis Corporation): Product Portfolio

Table 43 Cardinal Health (Cordis Corporation): Key Developments

Table 44 Cook Medical: Overview

Table 45 Cook Medical: Product Portfolio

Table 46 Cook Medical: Key Developments

Table 47 Cryolife: Overview

Table 48 Cryolife: Product Portfolio

Table 49 Cryolife: Key Developments

Table 50 Getinge Group: Overview

Table 51 Getinge Group: Product Portfolio

Table 52 Getinge Group: Key Developments

Table 53 LeMaitre Vascular Inc: Overview

Table 54 LeMaitre Vascular Inc: Product Portfolio

Table 55 LeMaitre Vascular Inc: Key Developments

Table 56 Medtronic PLC: Overview

Table 57 Medtronic PLC: Product Portfolio

Table 58 Medtronic PLC: Key Developments

Table 59 W.L. Gore & Associates Inc: Overview

Table 60 W.L. Gore & Associates Inc: Product Portfolio

Table 61 W.L. Gore & Associates Inc: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 2 Global Vascular Graft Market Share, By Product, 2022 & 2031 (%)

Figure 3 Global Vascular Graft Market Share, By Raw Material, 2022 & 2031 (%)

Figure 4 Global Vascular Graft Market Share, By End User, 2022 & 2031 (%)

Figure 5 Global Vascular Graft Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Vascular Graft Market Y-o-Y Growth, By Product, 2022-2031 (%)

Figure 7 Hemodialysis Access Graft Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 8 Endovascular Aneurysm Repair Stent Graft Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 9 Peripheral Vascular Graft Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 10 Global Vascular Graft Market Y-o-Y Growth, By Raw Material, 2022-2031 (%)

Figure 11 Polyester Raw Material in Global Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 12 Polytetrafluoroethylene (PTFE) Raw Material in Global Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 13 Polyurethane Raw Material in Global Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 14 Biosynthetic Raw Material in Global Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 15 Global Vascular Graft Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 16 Hospitals End User in Global Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 17 Specialty Clinics End User in Global Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 18 Ambulatory Surgery Center End User in Global Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 19 Global Vascular Graft Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 20 North America Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 21 Asia-Pacific Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 22 Europe Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 23 South America Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 24 Middle East and Africa Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 25 North America Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 26 North America Vascular Graft Market Share, By Product, 2022 & 2031 (%)

Figure 27 North America Vascular Graft Market Share, By Raw Material, 2022 & 2031 (%)

Figure 28 North America Vascular Graft Market Share, By End User, 2022 & 2031 (%)

Figure 29 North America Vascular Graft Market Share, By Country, 2022 & 2031 (%)

Figure 30 South America Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 31 South America Vascular Graft Market Share, By Product, 2022 & 2031 (%)

Figure 32 South America Vascular Graft Market Share, By Raw Material, 2022 & 2031 (%)

Figure 33 South America Vascular Graft Market Share, By End User, 2022 & 2031 (%)

Figure 34 South America Vascular Graft Market Share, By Country, 2022 & 2031 (%)

Figure 35 Europe Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 36 Europe Vascular Graft Market Share, By Product, 2022 & 2031 (%)

Figure 37 Europe Vascular Graft Market Share, By Raw Material, 2022 & 2031 (%)

Figure 38 Europe Vascular Graft Market Share, By End User, 2022 & 2031 (%)

Figure 39 Europe Vascular Graft Market Share, By Country, 2022 & 2031 (%)

Figure 40 Asia-Pacific Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 41 Asia-Pacific Vascular Graft Market Share, By Product, 2022 & 2031 (%)

Figure 42 Asia-Pacific Vascular Graft Market Share, By Raw Material, 2022 & 2031 (%)

Figure 43 Asia-Pacific Vascular Graft Market Share, By End User, 2022 & 2031 (%)

Figure 44 Asia-Pacific Vascular Graft Market Share, By Country, 2022 & 2031 (%)

Figure 45 Middle East & Africa Vascular Graft Market Value, 2022-2031 (USD Million)

Figure 46 Middle East & Africa Vascular Graft Market Share, By Product, 2022 & 2031 (%)

Figure 47 Middle East & Africa Vascular Graft Market Share, By Raw Material, 2022 & 2031 (%)

Figure 48 Middle East & Africa Vascular Graft Market Share, By End User, 2022 & 2031 (%)

Figure 49 Abbott Laboratories: Financials

Figure 50 Braun Melsungen AG: Financials

Figure 51 Bard Peripheral Vascular Inc. (BD): Financials

Figure 52 Cardinal Health (Cordis Corporation): Financials

Figure 53 Cook Medical: Financials

Figure 54 Cryolife: Financials

Figure 55 Getinge Group: Financials

Figure 56 LeMaitre Vascular Inc: Financials

Figure 57 Medtronic PLC: Financials

Figure 58 W.L. Gore & Associates Inc: Financials

글로벌 혈관 이식 시장 – 2023-2030

Global Vascular Graft Market - 2023-2030